Published in Oncogene on May 15, 2003
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int (2010) 1.98
Implication of snoRNA U50 in human breast cancer. J Genet Genomics (2009) 1.80
Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br J Cancer (2006) 1.30
Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Neuro Oncol (2005) 1.00
Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis. J Cancer (2010) 0.97
Negative regulators of insulin signaling revealed in a genome-wide functional screen. PLoS One (2009) 0.90
Impaired immune responses and prolonged allograft survival in Sly1 mutant mice. Mol Cell Biol (2005) 0.90
Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation. PLoS One (2010) 0.87
Immunoinhibitory adapter protein Src homology domain 3 lymphocyte protein 2 (SLy2) regulates actin dynamics and B cell spreading. J Biol Chem (2011) 0.85
miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer. Oncotarget (2015) 0.84
Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma. Eur J Hum Genet (2014) 0.84
Downregulation of SASH1 correlates with tumor progression and poor prognosis in ovarian carcinoma. Oncol Lett (2016) 0.80
SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer. Oncotarget (2016) 0.80
Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs. Clin Epigenetics (2016) 0.80
SASH1 inhibits proliferation and invasion of thyroid cancer cells through PI3K/Akt signaling pathway. Int J Clin Exp Pathol (2015) 0.80
A genome-wide association study to identify genomic modulators of rate control therapy in patients with atrial fibrillation. Am J Cardiol (2014) 0.79
Genomic characterization of ependymomas reveals 6q loss as the most common aberration. Oncol Rep (2014) 0.78
Clinical Significance of SASH1 Expression in Glioma. Dis Markers (2015) 0.78
The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development. BMC Immunol (2009) 0.77
SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype. J Invest Dermatol (2015) 0.77
Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations. PLoS One (2016) 0.76
Global gene expression analysis of lenses from different mouse strains and in the alpha3Cx46 knockout mouse. Mol Vis (2010) 0.76
Influence of Smoking Status and Intensity on Discovery of Blood Pressure Loci Through Gene-Smoking Interactions. Genet Epidemiol (2015) 0.76
Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response. Cell Death Dis (2016) 0.75
Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance. Oncoimmunology (2016) 0.75
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response. Cold Spring Harb Mol Case Stud (2016) 0.75
Genetic and familial predisposition to rotator cuff disease: a systematic review. J Shoulder Elbow Surg (2017) 0.75
Correlation of SASH1 expression and ultrasonographic features in breast cancer. Onco Targets Ther (2017) 0.75
A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation. J Cell Mol Med (2016) 0.75
Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy. Ann Clin Transl Neurol (2016) 0.75
p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation. J Cell Mol Med (2017) 0.75
The DNA sequence of the human X chromosome. Nature (2005) 6.97
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res (2005) 5.70
Prokaryotic sulfur oxidation. Curr Opin Microbiol (2005) 3.05
Sequence and analysis of chromosome 2 of Dictyostelium discoideum. Nature (2002) 3.01
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet (2002) 2.65
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol (2003) 2.30
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res (2004) 2.17
Insights into the evolution of the nucleolus by an analysis of its protein domain repertoire. Bioessays (2004) 1.96
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol (2004) 1.95
Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci (2011) 1.78
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res (2006) 1.66
Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett (2008) 1.54
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate (2003) 1.54
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol (2005) 1.51
Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer (2004) 1.49
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer (2009) 1.37
Genomic structures of the human and murine corin genes and functional GATA elements in their promoters. J Biol Chem (2002) 1.37
Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res (2004) 1.29
Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell (2004) 1.23
ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2. Oncogene (2004) 1.19
A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer (2006) 1.16
The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem Sci (2002) 1.11
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol (2005) 1.10
Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumors. Mol Cancer (2007) 1.06
An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med (Berl) (2009) 1.05
Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer. Int J Cancer (2014) 1.05
Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. Int J Cancer (2006) 1.04
Characterization of the human P-type 6-phosphofructo-1-kinase gene promoter in neural cell lines. Gene (2005) 1.04
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer (2003) 1.03
Analysis of DLC-1 expression in human breast cancer. J Cancer Res Clin Oncol (2003) 1.02
ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. Cancer Lett (2004) 1.01
Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas. Pancreatology (2003) 1.00
Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome. Cell Signal (2004) 0.99
Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms. Genes Chromosomes Cancer (2003) 0.96
Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene (2004) 0.95
An online brain-machine interface using decoding of movement direction from the human electrocorticogram. J Neural Eng (2012) 0.95
Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics (2004) 0.94
The ethics of uncertainty. In the light of possible dangers, research becomes a moral duty. EMBO Rep (2007) 0.92
Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer. Cancer Res (2005) 0.92
Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Genes Chromosomes Cancer (2006) 0.92
A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family. FEBS Lett (2002) 0.91
Comparison of gene expression data from human and mouse breast cancers: identification of a conserved breast tumor gene set. Int J Cancer (2007) 0.90
Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. J Cancer Res Clin Oncol (2005) 0.90
Geographical distribution of hantaviruses in Thailand and potential human health significance of Thailand virus. Am J Trop Med Hyg (2006) 0.90
Characterization of a cyanobacterial-like uptake [NiFe] hydrogenase: EPR and FTIR spectroscopic studies of the enzyme from Acidithiobacillus ferrooxidans. J Biol Inorg Chem (2006) 0.90
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther (2005) 0.89
Para-phenylenediamine-specific lymphocyte activation test: a sensitive in vitro assay to detect para-phenylenediamine sensitization in patients with severe allergic reactions. Exp Dermatol (2010) 0.89
Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes (2005) 0.88
Suppression of polyploidy by the BRCA2 protein. Cancer Lett (2007) 0.86
Different structural organization of the encephalopsin gene in man and mouse. Gene (2002) 0.86
Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity. Mol Endocrinol (2002) 0.85
Indocyanine green angiography in the presence of subretinal or intraretinal haemorrhages: clinical and experimental investigations. Clin Experiment Ophthalmol (2002) 0.84
SoxV transfers electrons to the periplasm of Paracoccus pantotrophus - an essential reaction for chemotrophic sulfur oxidation. Microbiology (2006) 0.84
Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat (2003) 0.82
Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51. Genes Chromosomes Cancer (2005) 0.81
Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway. Biol Chem (2007) 0.80
Mutation analysis and mRNA expression of trail-receptors in human breast cancer. Int J Cancer (2002) 0.80
The role of ECoG magnitude and phase in decoding position, velocity, and acceleration during continuous motor behavior. Front Neurosci (2013) 0.79
The Spin/Ssty repeat: a new motif identified in proteins involved in vertebrate development from gamete to embryo. Genome Biol (2001) 0.79
Epitope mapping of antibodies against S-tagged fusion proteins and molecular weight markers. Biosci Biotechnol Biochem (2008) 0.78
Lymphoma outbreak in a GASH:Sal hamster colony. Arch Virol (2013) 0.78
Chimeric polyomavirus-derived virus-like particles: the immunogenicity of an inserted peptide applied without adjuvant to mice depends on its insertion site and its flanking linker sequence. Viral Immunol (2007) 0.78
Identification and characterization of KAT, a novel gene preferentially expressed in several human cancer cell lines. Biol Chem (2003) 0.78
Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom. J Allergy Clin Immunol (2013) 0.78
SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium. Int J Cancer (2008) 0.77
Physical and transcriptional map of the critical region for keratolytic winter erythema (KWE) on chromosome 8p22-p23 between D8S550 and D8S1759. Eur J Hum Genet (2002) 0.77
A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8. Oncogene (2005) 0.77
Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells. Virus Genes (2006) 0.77
Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice. Viral Immunol (2002) 0.76
Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Derm Venereol (2012) 0.76
Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer. Ann N Y Acad Sci (2004) 0.76
Manifestation of rheumatoid arthritis during subcutaneous allergen-specific immunotherapy with bee venom. J Allergy Clin Immunol (2012) 0.75